| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 2,021,906 | $525,695 | $0.2600 | 18 Jun 2025 | By Bios Fund III QP, LP | ||
| Common Stock | 1,424,014 | $370,243 | $0.2600 | 18 Jun 2025 | By Bios Memory SPV I, LP | ||
| Common Stock | 500,095 | $130,024 | $0.2600 | 18 Jun 2025 | By Bios Clinical Opportunity Fund, LP | ||
| Common Stock | 418,926 | $108,920 | $0.2600 | 18 Jun 2025 | By Bios Fund I, LP | ||
| Common Stock | 385,248 | $100,164 | $0.2600 | 18 Jun 2025 | By Bios Memory SPV II, LP | ||
| Common Stock | 326,733 | $84,950 | $0.2600 | 18 Jun 2025 | By Bios Fund III NT, LP | ||
| Common Stock | 309,748 | $80,534 | $0.2600 | 18 Jun 2025 | By Bios Fund III, LP | ||
| Common Stock | 255,765 | $66,498 | $0.2600 | 18 Jun 2025 | By Bios Fund II QP, LP | ||
| Common Stock | 245,029 | $63,707 | $0.2600 | 18 Jun 2025 | By Bios Fund I QP, LP | ||
| Common Stock | 78,298 | $20,357 | $0.2600 | 18 Jun 2025 | By Bios Fund II, LP | ||
| Common Stock | 48,500 | $12,610 | $0.2600 | 18 Jun 2025 | Indirect | ||
| Common Stock | 34,238 | $8,901 | $0.2600 | 18 Jun 2025 | By Bios Fund II NT, LP |
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|